Literature DB >> 32480072

Surgical Management of the Axilla in Elderly Women With Node-Positive Breast Cancer.

Caitlin E Marks1, Yi Ren2, Laura H Rosenberger3, Samantha M Thomas2, Rachel A Greenup3, Oluwadamilola M Fayanju4, Susan McDuff5, Gretchen Kimmick6, E Shelley Hwang3, Jennifer K Plichta7.   

Abstract

BACKGROUND: Elderly women with clinically node-positive (cN+) breast cancer (BC) often have comorbidities that limit life expectancy and complicate treatment. We sought to determine whether the number of lymph nodes (LNs) retrieved among older women with node-positive BC was associated with overall survival (OS).
METHODS: Using the National Cancer Database (2010-2015), women 70-90 y with cN + BC and ≥1 LNs removed were categorized by treatment sequence: upfront surgery or neoadjuvant chemotherapy (NAC). Multivariable Cox proportional hazards models with restricted cubic splines characterized the functional association of LN retrieval with OS; threshold values of LN retrieval were estimated. Cox proportional hazards models were used to estimate the association of LN retrieval groups with OS.
RESULTS: In the upfront surgery cohort, a nonlinear association was identified between LNs retrieved and OS. In the NAC cohort, no association was identified. For the upfront surgery cohort, the optimal threshold value of LN retrieval was 21 LNs (90% confidence interval 18-23). Based on this estimate, LN retrieval groups were created: <6, 6-11, 12-17, 18-23, and >23 LNs. After adjustment, retrieval of <12 LNs in the upfront surgery group was associated with a worse OS. No differences were observed in the NAC group.
CONCLUSIONS: For elderly women receiving upfront surgery, there is no survival benefit to removing more than 12 LNs, and for those receiving NAC, there is no association between number of LNs removed and survival. In older women who present with cN + BC, aggressive surgery to remove more than 12 LNs may not be necessary.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axillary lymph node dissection; Breast cancer; Elderly; Node-positive

Mesh:

Year:  2020        PMID: 32480072      PMCID: PMC7483590          DOI: 10.1016/j.jss.2020.04.036

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

1.  Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma.

Authors:  Jeanne S Mandelblatt; Stephen B Edge; Neal J Meropol; Ruby Senie; Theodore Tsangaris; Luther Grey; Burt Peterson; Yi-Ting Hwang; Jane C Weeks
Journal:  Cancer       Date:  2002-12-15       Impact factor: 6.860

2.  Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.

Authors:  Penny Fang; Weiguo He; Daniel R Gomez; Karen E Hoffman; Benjamin D Smith; Sharon H Giordano; Reshma Jagsi; Grace L Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-02-01       Impact factor: 7.038

3.  The influence of comorbidities on overall survival among older women diagnosed with breast cancer.

Authors:  Jennifer L Patnaik; Tim Byers; Carolyn Diguiseppi; Thomas D Denberg; Dana Dabelea
Journal:  J Natl Cancer Inst       Date:  2011-06-30       Impact factor: 13.506

4.  Causes of death and relative survival of older women after a breast cancer diagnosis.

Authors:  Mara A Schonberg; Edward R Marcantonio; Long Ngo; Donglin Li; Rebecca A Silliman; Ellen P McCarthy
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

5.  Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.

Authors:  C Bonneau; D Hequet; J P Estevez; N Pouget; R Rouzier
Journal:  Eur J Surg Oncol       Date:  2015-04-25       Impact factor: 4.424

6.  Limiting comorbid conditions and breast cancer stage at diagnosis.

Authors:  P A Vaeth; W A Satariano; D R Ragland
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-10       Impact factor: 6.053

7.  Extent of metastatic axillary involvement in 1446 cases of breast cancer.

Authors:  U Veronesi; A Luini; V Galimberti; S Marchini; V Sacchini; F Rilke
Journal:  Eur J Surg Oncol       Date:  1990-04       Impact factor: 4.424

8.  Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

Authors:  Abigail S Caudle; Wei T Yang; Savitri Krishnamurthy; Elizabeth A Mittendorf; Dalliah M Black; Michael Z Gilcrease; Isabelle Bedrosian; Brian P Hobbs; Sarah M DeSnyder; Rosa F Hwang; Beatriz E Adrada; Simona F Shaitelman; Mariana Chavez-MacGregor; Benjamin D Smith; Rosalind P Candelaria; Gildy V Babiera; Basak E Dogan; Lumarie Santiago; Kelly K Hunt; Henry M Kuerer
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

9.  Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Authors:  Gunter von Minckwitz; Chiun-Sheng Huang; Max S Mano; Sibylle Loibl; Eleftherios P Mamounas; Michael Untch; Norman Wolmark; Priya Rastogi; Andreas Schneeweiss; Andres Redondo; Hans H Fischer; William Jacot; Alison K Conlin; Claudia Arce-Salinas; Irene L Wapnir; Christian Jackisch; Michael P DiGiovanna; Peter A Fasching; John P Crown; Pia Wülfing; Zhimin Shao; Elena Rota Caremoli; Haiyan Wu; Lisa H Lam; David Tesarowski; Melanie Smitt; Hannah Douthwaite; Stina M Singel; Charles E Geyer
Journal:  N Engl J Med       Date:  2018-12-05       Impact factor: 176.079

10.  Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

Authors:  Abram Recht; Elizabeth A Comen; Richard E Fine; Gini F Fleming; Patricia H Hardenbergh; Alice Y Ho; Clifford A Hudis; E Shelley Hwang; Jeffrey J Kirshner; Monica Morrow; Kilian E Salerno; George W Sledge; Lawrence J Solin; Patricia A Spears; Timothy J Whelan; Mark R Somerfield; Stephen B Edge
Journal:  Ann Surg Oncol       Date:  2016-09-19       Impact factor: 5.344

View more
  2 in total

Review 1.  Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer.

Authors:  Liang Shang; Xinglu Zhou; Jiarui Zhang; Yujie Shi; Lei Zhong
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

2.  Mortality in Older Patients with Breast Cancer Undergoing Breast Surgery: How Low is "Low Risk"?

Authors:  Jacquelyn Dillon; Samantha M Thomas; Laura H Rosenberger; Gayle DiLalla; Oluwadamilola M Fayanju; Carolyn S Menendez; E Shelley Hwang; Jennifer K Plichta
Journal:  Ann Surg Oncol       Date:  2021-07-26       Impact factor: 4.339

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.